Effectiveness of exenatide in Asian Indians in a clinical care setting.

Diabetes technology & therapeutics

Volumn 12, Issue 8, 2010, Pages 613-618

  Sudhakaran, Chidambarann ^a   Fathima, Maryam ^b   Anjana, Ranjit Mohan ^b   Unnikrishnan, Ranjit I ^b   Mohan, Viswanathan ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; EXENDIN 4; GLARGINE; GLYCOSYLATED HEMOGLOBIN; INSULIN; ISOPHANE INSULIN; PEPTIDE; VENOM;

ADULT; AGED; ARTICLE; ASIAN; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INDIA; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INDIA; INSULIN; INSULIN, NPH; MALE; MIDDLE AGED; PEPTIDES; QUESTIONNAIRES; TREATMENT OUTCOME; VENOMS;

EID: 77957653098     PISSN: None     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2010.0033     Document Type: Article

References (0)